Covista Inc (CVSA)

Currency in USD
124.27
-0.88(-0.70%)
Closed·
124.70+0.43(+0.35%)
·
CVSA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
122.43125.55
52 wk Range
86.97156.26
Key Statistics
Prev. Close
124.27
Open
123.91
Day's Range
122.43-125.55
52 wk Range
86.97-156.26
Volume
234.93K
Average Volume (3m)
334.47K
1-Year Change
-4.1866%
Book Value / Share
39.53
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CVSA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
156.25
Upside
+25.73%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Covista Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 156.25
(+25.73% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Buy140.00+12.66%130.00Maintain11/05/2026
BMO Capital
Buy140.00+12.66%138.00Maintain07/04/2026
BMO Capital
Buy138.00+11.05%125.00Maintain30/01/2026
Baird
Buy163.00+31.17%169.00Maintain31/10/2025
BMO Capital
Buy158.00+27.14%172.00Maintain31/10/2025

Covista Inc Earnings Call Summary for Q2/2026

  • Adtalem reported Q2 2026 EPS of $2.43 (10.96% above forecast) and revenue of $503.4M (up 12.4% YoY), though stock fell 6.46% in after-hours trading.
  • Enrollment increased for the 10th consecutive quarter to 97,000 students, with the company maintaining leadership in nursing and healthcare education.
  • Financial performance showed strong growth with adjusted EBITDA up 23.9% to $154.9M and 1.7M shares repurchased at an average price of $95.
  • Management raised full-year adjusted EPS guidance to $7.80-$8.00 (17%-20% growth) and projected revenue between $1.9B-$1.94B (6%-8.5% increase).
  • CEO Steve Beard highlighted Adtalem's position as 'America's largest healthcare educator' addressing workforce shortages, while CFO noted $428M in trailing twelve-month operating cash flow.
Last Updated: 03/02/2026, 10:54
Read Full Transcript

Earnings

Latest Release
07/05/2026
EPS / Forecast
1.98 / 1.72
Revenue / Forecast
487M / 474.01M
EPS Revisions
Last 90 days

Compare CVSA to Peers and Sector

Metrics to compare
CVSA
Peers
Sector
Relationship
P/E Ratio
16.9x12.4x10.4x
PEG Ratio
2.520.410.02
Price/Book
3.1x3.6x1.4x
Price / LTM Sales
2.2x2.5x0.9x
Upside (Analyst Target)
25.6%19.6%29.2%
Fair Value Upside
Unlock16.0%11.3%Unlock

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor’s, master’s, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
20.20M59.36%2.51B
Other Institutional Investors
15.77M40.64%1.96B
Public Companies & Retail Investors
0.000.00%0.00
Total
35.97M100.00%4.47B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.15.37%5,229,253649,839
The Vanguard Group, Inc.12.78%4,348,951540,444

People Also Watch

5.730
SBS
+1.24%
33.89
PRDO
-0.26%
57.52
EXPO
-0.43%
129.49
ARCB
+3.95%
115.08
ROAD
+1.97%

FAQ

What Is the Covista (NYSE: CVSA) Share Price Today?

The Covista stock price today is 124.27 USD.

What Stock Exchange Does Covista (CVSA) Trade On?

Covista is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Covista?

The stock symbol (also called a 'ticker') for Covista is "CVSA."

What Is the Current Covista Market Capitalisation?

As of today, Covista (NYSE: CVSA) market cap is 4.23B USD.

What Is Covista's (CVSA) Earnings Per Share (TTM)?

The Covista EPS is currently 6.86 (Trailing Twelve Months).

When Is the Next Covista Earnings Date?

Covista's next earnings report will be released on 06/08/2026.

Is CVSA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Covista moving averages and other technical indicators, the daily buy/sell signal for CVSA stock is Neutral.

How Many Times Has Covista Stock Split?

Covista has split 3 times. (See the CVSA stock split history page for full effective split date and price information.)

How Many Employees Does Covista Have?

Covista has 4727 employees, based on their latest Companies House report.

What is the current trading status of Covista (NYSE: CVSA)?

As of 27/05/2026, Covista (CVSA) is trading at a share price of 124.27 USD, with a previous close of 124.27 USD. The stock has fluctuated within a day range of 122.43 USD to 125.55 USD, while its 52-week range spans from 86.97 USD to 156.26 USD.

What Is Covista (CVSA) Price Target According to Analysts?

The average 12-month price target for Covista is 156.25 USD, with a high estimate of 175 USD and a low estimate of 140 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +25.73% Upside potential.

What Is the CVSA After Hours Price?

CVSA's last after hours stock price is 124.70 USD, the stock has decreased by 0.43, or 0.35%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.